Susan Baglino

Susan Baglino, MS, PMP, currently serves as Senior Director of Clinical Development at Opthea, overseeing Phase III registrational trials and ensuring the quality of clinical data for regulatory submissions. With a robust background in clinical operations and project management, Susan has significantly reduced protocol deviations, improved data quality through targeted reviews, and achieved timely delivery of clean clinical data. Prior roles include Director of Clinical Sciences at Iveric Bio, where contributions led to successful NDA submissions and FDA approval of new therapies, and Director of Clinical Development at Adverum Biotechnologies, where oversight of gene therapy trials ensured participant safety and data integrity. Susan's expertise spans across various phases of clinical trials and includes significant experience in regulatory affairs, scientific communication, and team management, contributing to multiple successful drug approvals throughout a progressive career that began at Bristol-Myers Squibb. Susan holds a Master's degree in Molecular Biology from Lehigh University and a certificate in Clinical Development and Regulatory Affairs.